Rezafungin (CD101) demonstrates potent in vitro activity against Aspergillus, including azole-resistant Aspergillus fumigatus isolates and cryptic species
Author:
Affiliation:
1. Fungus Testing Laboratory, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
2. Cidara Therapeutics, Inc., San Diego, CA, USA
Funder
Cidara Therapeutics, Inc
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)
Link
http://academic.oup.com/jac/article-pdf/73/11/3063/26144555/dky280.pdf
Reference22 articles.
1. International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus;Verweij;Drug Resist Updat,2015
2. A rationale for reduced-frequency dosing of anidulafungin for antifungal prophylaxis in immunocompromised patients;Bruggemann;J Antimicrob Chemother,2015
3. Micafungin twice weekly as antifungal prophylaxis in paediatric patients at high risk for invasive fungal disease;Bochennek;J Antimicrob Chemother,2015
4. CD101, a long-acting echinocandin, and comparator antifungal agents tested against a global collection of invasive fungal isolates in the SENTRY 2015 Antifungal Surveillance Program;Pfaller;Int J Antimicrob Agents,2017
5. Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates;Pfaller;J Antimicrob Chemother,2016
Cited by 55 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Novel Antifungals and Aspergillus Section Terrei with Potpourri Susceptibility Profiles to Conventional Antifungals;Journal of Fungi;2023-06-06
2. Recent drug development and treatments for fungal infections;Brazilian Journal of Microbiology;2023-05-23
3. Invasive Pulmonary Aspergillosis in Coronavirus Disease 2019 Patients Lights and Shadows in the Current Landscape;Advances in Respiratory Medicine;2023-05-08
4. Development of nanodrug-based eye drops with good penetration properties and ROS responsiveness for controllable release to treat fungal keratitis;NPG Asia Materials;2023-05-05
5. The antifungal pipeline for invasive fungal diseases: what does the future hold?;Expert Review of Anti-infective Therapy;2023-04-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3